Literature DB >> 22755372

Acute myeloid leukaemia in children: experience at a tertiary care facility of Pakistan.

Zehra Fadoo1, Naureen Mushtaq, Saima Alvi, Muhammad Ali.   

Abstract

OBJECTIVE: To document the demographics and outcome of children with Acute Myeloid Leukemia (AML) treated at a tertiary care facility of Pakistan.
METHODS: A retrospective study was conducted at Aga Khan University on children (less than 15 years) diagnosed to have AML between January 2000 to May 2007.Total 40 cases were diagnosed out of which 37 charts were available for review.
RESULTS: The average age of presentation was 8.5 +/- 4.5 years and 75% were males. The most common presenting feature was fever in 83% followed by bleeding in 41% and pallor in 39%. Initial WBC of > 100,000 was seen in 19% of patients. The most common FAB subtype was M4 39%. Twenty three patients underwent treatment out of which 12 patients are alive and in remission. Majority were followed up around 2 years and 6 months. Out of the 11 patients who died three had resistant disease, four relapsed and rest died due to sepsis mostly during induction.
CONCLUSIONS: The most common sub type in our study is AML M4 although AML M2 is reported as predominant subtype. About a third of the patients could not start or complete therapy due to financial constraints. The overall survival for our patients who completed therapy was 52%.

Entities:  

Mesh:

Year:  2012        PMID: 22755372

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  2 in total

1.  Prognostic Factors in Childhood Acute Myeloid Leukemia; Experience from A Developing Country.

Authors:  Tariq Ghafoor; Sumaira Khalil; Tanzeela Farah; Shakeel Ahmed; Imtenan Sharif
Journal:  Cancer Rep (Hoboken)       Date:  2020-07-09

2.  Infectious events prior to chemotherapy initiation in children with acute myeloid leukemia.

Authors:  Carol Portwine; David Mitchell; Donna Johnston; Biljana Gillmeister; Marie-Chantal Ethier; Rochelle Yanofsky; David Dix; Sonia Cellot; Victor Lewis; Victoria Price; Mariana Silva; Shayna Zelcer; Lynette Bowes; Bruno Michon; Kent Stobart; Josee Brossard; Joseph Beyene; Lillian Sung
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.